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A critical complication of the obesity epidemic experienced in Westernized 
societies is nonalcoholic fatty liver disease (NAFLD).  NAFLD, fatty liver not due 
to alcohol consumption, is the most common chronic liver disease and 
associated with increasing morbidity, mortality, and demand for liver 
transplantation.  NAFLD is a progressive disease with a histological spectrum 
ranging from hepatic steatosis to nonalcoholic steatohepatitis, advanced fibrosis, 
and cirrhosis.  Approximately one third of all US adults (90 million) have fatty 
livers, with prevalence rates as high as 75-100% in the obese and morbidly 
obese.  With growing health problems associated with NAFLD, major questions 
facing research scientists and health care providers are what are the 
mechanisms responsible for NAFLD development and what is the best treatment 
strategy.  Since drug interventions appear to be only marginally successful, the 
cornerstone therapy for NAFLD remains lifestyle modifications of exercise and 
weight loss.  However, while recent cross-sectional observations suggest that 
being more physically active is inversely associated with NAFLD, studies which 
attempt to identify molecular mechanisms underlying the effects of lifestyle 
modifications on NAFLD are lacking.   To address these clinical questions, we 
have taken an interdisciplinary approach with collaborations from experts in 
multiple departments and facilities at the University of Missouri, including 
Nutrition and Exercise Physiology, Hepatology, Veterinary Biomedical Sciences, 
and VA investigators.  In addition, we have utilized a unique animal model, the 
hyperphagic Otsuka Long-Evans Tokushima Fatty (OLETF) rat that develops 
obesity, insulin resistance and overt type 2 diabetes, a model which we liken to 
overeating, sedentary, obese humans.  Through a series of experiments, we 
found that the natural progression pattern of fatty liver disease in the sedentary 
OLETF rat closely resembles the human condition (progression from simple 
hepatic steatosis to hepatocyte ballooning, fibrosis, and inflammation).  We also 
have compelling evidence that hepatic mitochondrial dysfunction is present at an 
early age and mitochondrial content, function, and mitochondrial health are 
disrupted with disease progression, suggesting a potential primary event in 
NAFLD in this animal model.  However and perhaps even more important, when 
OLETF rats are given access to voluntary running wheels and allowed to 
exercise daily, the initiation and progression of NAFLD is completely prevented.  
These benefits occur through modification in both peripheral and hepatic factors, 
including maintenance of glycemic control and enhancement of hepatic 
mitochondrial content and function.  We are currently in the process of translating 
these very exciting findings in a randomized, human clinical trial examining the 
impact of different lifestyle modifications in the treatment of NAFLD.  Findings 
from our research group have important public health application, particularly for 
the 60-80% of Americans who overeat, who are overweight, and who are 
physically inactive.  
